Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01844739 · ClinicalTrials.gov registry record · Phase 1
A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel
A Phase 1 study, sponsored by Novan.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01844739 is a Phase 1 study that has completed, run by Novan. The registered enrollment target is 30 participants.
The verdict
NCT01844739, a Phase 1 study, has completed, sponsored by Novan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a 2 week Phase 1 study of SB204 (NVN1000 Gel) in healthy adult volunteers with elevated Propionibacterium acnes (P. acnes) counts. Subjects will apply NVN1000 4% Gel or Vehicle Gel twice daily to their face. Assessments will include cutaneous tolerability, safety, and P. acnes counts.
Interventions
- DRUG Vehicle Gel
- DRUG NVN1000 4% Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01844739
The ClinicalTrials.gov registry entry for NCT01844739 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novan, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle Gel is the first listed.
NCT01844739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01844739 about?
NCT01844739 is a clinical study titled "A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel". This is a 2 week Phase 1 study of SB204 (NVN1000 Gel) in healthy adult volunteers with elevated Propionibacterium acnes (P. acnes) counts. Subjects will apply NVN1000 4% Gel or Vehicle Gel twice daily to their face. Assessments will include cutaneous tolerability, safety, and P. acnes counts.
What is the current status of trial NCT01844739?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2013-04. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01844739?
The interventions under investigation include: Vehicle Gel (DRUG), NVN1000 4% Gel (DRUG).
Who is sponsoring clinical trial NCT01844739?
This trial is sponsored by Novan, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.